Guardion Health Sciences Inc (NASDAQ:GHSI) Sees Large Growth in Short Interest
Guardion Health Sciences Inc (NASDAQ:GHSI) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totalling 203,100 shares, an increase of 735.8% from the July 31st total of 24,300 shares. Currently, 2.0% of the shares of the stock are short sold. Based on an average trading volume of 2,310,000 shares, the days-to-cover ratio is currently 0.1 days.
NASDAQ GHSI traded up $0.01 during trading on Wednesday, hitting $0.27. 5,761,963 shares of the company’s stock were exchanged, compared to its average volume of 1,687,518. The company has a current ratio of 5.40, a quick ratio of 4.80 and a debt-to-equity ratio of 0.10. Guardion Health Sciences has a fifty-two week low of $0.20 and a fifty-two week high of $4.00. The firm’s 50 day moving average price is $0.57.
Guardion Health Sciences (NASDAQ:GHSI) last posted its earnings results on Monday, August 12th. The company reported ($0.14) EPS for the quarter. Guardion Health Sciences had a negative return on equity of 243.25% and a negative net margin of 780.75%. The company had revenue of $0.26 million during the quarter.
Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
Read More: Why is total return important?
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.